Nisa Investment Advisors
TNXP icon

Nisa Investment Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Nisa Investment Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Buy
+4,942
New +$63.8K ﹤0.01% 1759
2026
Q1 		– Sell
-10,000
Closed -$156K – 3123
2025
Q4 		$156K Sell
10,000
-4,800
-32% -$88.5K ﹤0.01% 1292
2025
Q3 		$358K Buy
+14,800
New +$549K ﹤0.01% 1111
2021
Q3 		– Hold
0
– -$46K – 2331
2021
Q2 		– Hold
0
– – – 1965

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nisa Investment Advisors's TNXP Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 4,942 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #1759 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in TNXP as recently as Q4 2025.

Nisa Investment Advisors first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $358K in Q3 2025. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Nisa Investment Advisors held 4,942 shares of Tonix Pharmaceuticals worth $63.1K as of Q2 2026.
  • Tonix Pharmaceuticals was a new Nisa Investment Advisors position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1759 holding.
  • Nisa Investment Advisors first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Nisa Investment Advisors's Tonix Pharmaceuticals position peaked at $358K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.